Neelufar Mozaffarian, M.D., Ph.D., FACR
Board Member
Fate Therapeutics Inc (FATE)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Neelufar Mozaffarian, M.D., Ph.D., FACR
Neelufar Mozaffarian, M.D., Ph.D., FACR is recorded as Board Member at Fate Therapeutics Inc (FATE). Fate Therapeutics Inc reported in an 8-K filed July 31, 2024 that Neelufar Mozaffarian, M.D., Ph.D., FACR was appointed Class II director and member of the NCG Committee and the Science and Technology Committee of the Board, effective July 29, 2024.
“On July 29, 2024, the Board, following a recommendation from the Nominating and Corporate Governance Committee of the Board (the "NCG Committee"), appointed Neelufar Mozaffarian, M.D., Ph.D., FACR, to the Board, to serve as a Class II director and member of the NCG Committee and the Science and Technology Committee of the Board.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2024-07-29–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Fate Therapeutics Inc
Other people whose current roles at this company are on record from its filings.
- Bahram Valamehr CEO, Board Member
- Scott Wolchko CEO, Board Member
- William H. Rastetter Chairman
- J. Scott Wolchko CFO, Chief Accounting Officer
- Kamal Adawi CFO, Chief Accounting Officer
- Cindy R. Tahl General Counsel
- Edward J. Dulac III Chief Accounting Officer
- Karin Jooss Board Member
- Karin Jooss, Ph.D. Board Member
- Laura J. Hamill Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.